Sex-specific distribution of cancer types and contact allergy
| Cancer groups (NORDCAN) | Sex | Total | |||||
| Men | Women | ||||||
| No contact allergy | Contact allergy | Total | No contact allergy | Contact allergy | Total | ||
| Pancreas | 11 | 4 | 15 | 13 | 17 | 30 | 45 |
| 24.4% | 8.9% | 33.3% | 28.9% | 37.8% | 66.7% | 100% | |
| Brain/CNS | 15 | 7 | 22 | 30 | 11 | 41 | 63 |
| 23.8% | 11.1% | 34.9% | 47.6% | 17.5% | 65.1% | 100% | |
| Cervix uteri | NA | NA | NA | 34 | 30 | 64 | 64 |
| 53.1% | 46.9% | 100% | 100% | ||||
| Leukaemia | 27 | 7 | 34 | 24 | 13 | 37 | 71 |
| 38.0% | 9.9% | 47.9% | 33.8% | 18.3% | 52.1% | 100% | |
| Lip, oral cavity and pharynx | 30 | 15 | 45 | 16 | 12 | 28 | 73 |
| 41.1% | 20.5% | 61.6% | 21.9% | 16.4% | 38.4% | 100% | |
| Corpus uteri | NA | NA | NA | 48 | 38 | 86 | 86 |
| 55.8% | 44.2% | 100% | 100% | ||||
| Rectum and anus | 41 | 14 | 55 | 29 | 17 | 46 | 101 |
| 40.6% | 13.9 | 54.5% | 28.7% | 16.8% | 45.5% | 100% | |
| Melanoma of skin | 32 | 11 | 43 | 40 | 21 | 61 | 104 |
| 30.8% | 10.6% | 41.3% | 38.5% | 20.2% | 58.7% | 100% | |
| Prostate | 86 | 36 | 122 | NA | NA | NA | 122 |
| 70.5% | 29.5% | 100% | 100% | ||||
| Colon | 43 | 9 | 52 | 43 | 29 | 72 | 124 |
| 34.7% | 7.3% | 41.9% | 34.7% | 23.4% | 58.1% | 100% | |
| Bladder, etc | 63 | 33 | 96 | 21 | 22 | 43 | 139 |
| 45.3% | 23.7% | 69.1% | 15.1% | 15.8% | 30.9% | 100% | |
| Lung | 83 | 26 | 109 | 41 | 42 | 83 | 192 |
| 43.2% | 13.5% | 56.8% | 21.4% | 21.9% | 43.2% | 100% | |
| Colorectal | 83 | 23 | 106 | 71 | 46 | 117 | 223 |
| 37.2% | 10.3% | 47.5% | 31.8% | 20.6% | 52.5% | 100% | |
| Breast | 0 | 0 | 0 | 248 | 151 | 399 | 399 |
| 62.2% | 37.8% | 100% | 100% | ||||
| Skin, non-melanoma | 203 | 72 | 275 | 284 | 166 | 450 | 725 |
| 28.0% | 9.9% | 37.9% | 39.2% | 22.9% | 62.1% | 100% | |
| All sites but non-melanoma skin cancer | 531 | 209 | 740 | 663 | 452 | 1115 | 1855 |
| 28.6% | 11.3% | 39.9% | 35.7% | 24.4% | 60.1% | 100% | |
| Total (allergy database) | 4519 | 1594 | 6113 | 4471 | 6338 | 10 809 | 16 922 |
| 26.7% | 9.4% | 36.1% | 26.4% | 37.5% | 63.9% | 100% | |
The cancer types are sorted ascendingly according to the total number of patients with the respective cancer type. Only cancer types with ≥40 patients were included in the logistic regression analyses. CNS, central nervous system.